223 related articles for article (PubMed ID: 16972708)
1. Confirmatory clinical trials with an adaptive design.
Koch A
Biom J; 2006 Aug; 48(4):574-85. PubMed ID: 16972708
[TBL] [Abstract][Full Text] [Related]
2. How practical are adaptive designs likely to be for confirmatory trials?
Gould AL
Biom J; 2006 Aug; 48(4):644-9; discussion 660-2. PubMed ID: 16972716
[TBL] [Abstract][Full Text] [Related]
3. Biostatistical methods for demonstrating efficacy in the regulatory setting. An epistemological approach to adaptive designs.
Koch A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 May; 48(5):572-9. PubMed ID: 15887068
[TBL] [Abstract][Full Text] [Related]
4. Plan to be flexible: a commentary on adaptive designs.
Shih WJ
Biom J; 2006 Aug; 48(4):656-9; discussion 660-2. PubMed ID: 16972718
[TBL] [Abstract][Full Text] [Related]
5. Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: opportunities and limitations.
Jenniso C; Turnbull BW
Biom J; 2006 Aug; 48(4):650-5; discussion 660-2. PubMed ID: 16972717
[TBL] [Abstract][Full Text] [Related]
6. Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: applications and practical considerations.
Schmidli H; Bretz F; Racine A; Maurer W
Biom J; 2006 Aug; 48(4):635-43. PubMed ID: 16972715
[TBL] [Abstract][Full Text] [Related]
7. Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: general concepts.
Bretz F; Schmidli H; König F; Racine A; Maurer W
Biom J; 2006 Aug; 48(4):623-34. PubMed ID: 16972714
[TBL] [Abstract][Full Text] [Related]
8. Response adaptive randomization procedures in seamless phase II/III clinical trials.
Zhu H; Piao J; Lee JJ; Hu F; Zhang L
J Biopharm Stat; 2020; 30(1):3-17. PubMed ID: 31454295
[TBL] [Abstract][Full Text] [Related]
9. Practical guidelines for adaptive seamless phase II/III clinical trials that use Bayesian methods.
Kimani PK; Glimm E; Maurer W; Hutton JL; Stallard N
Stat Med; 2012 Aug; 31(19):2068-85. PubMed ID: 22437262
[TBL] [Abstract][Full Text] [Related]
10. Seamless Phase II/III combination study through response adaptive randomization.
Wang L; Cui L
J Biopharm Stat; 2007; 17(6):1177-87. PubMed ID: 18027224
[TBL] [Abstract][Full Text] [Related]
11. Group-sequential methods for adaptive seamless phase II/III clinical trials.
Stallard N
J Biopharm Stat; 2011 Jul; 21(4):787-801. PubMed ID: 21516569
[TBL] [Abstract][Full Text] [Related]
12. New designs for the selection of treatments to be tested in randomized clinical trials.
Simon R; Thall PF; Ellenberg SS
Stat Med; 1994 Mar 15-Apr 15; 13(5-7):417-29. PubMed ID: 8023026
[TBL] [Abstract][Full Text] [Related]
13. Opening the adaptive toolbox.
Wittes J; Lachenbruch PA
Biom J; 2006 Aug; 48(4):598-603; discussion 613-22. PubMed ID: 16972711
[TBL] [Abstract][Full Text] [Related]
14. Quantitative decision-making in randomized Phase II studies with a time-to-event endpoint.
Huang B; Talukder E; Han L; Kuan PF
J Biopharm Stat; 2019; 29(1):189-202. PubMed ID: 29969380
[TBL] [Abstract][Full Text] [Related]
15. Statistical inference for response adaptive randomization procedures with adjusted optimal allocation proportions.
Zhu H
J Biopharm Stat; 2017; 27(5):732-740. PubMed ID: 27937121
[TBL] [Abstract][Full Text] [Related]
16. An adaptive group sequential design for phase II/III clinical trials that select a single treatment from several.
Kelly PJ; Stallard N; Todd S
J Biopharm Stat; 2005; 15(4):641-58. PubMed ID: 16022169
[TBL] [Abstract][Full Text] [Related]
17. Adaptive designs for binary treatment responses in phase III clinical trials: controversies and progress.
Biswas A
Stat Methods Med Res; 2001 Oct; 10(5):353-64. PubMed ID: 11697227
[TBL] [Abstract][Full Text] [Related]
18. Statistical principles: myths or facts?
Sylvester R
Onkologie; 2003 Dec; 26(6):520-1. PubMed ID: 14709923
[No Abstract] [Full Text] [Related]
19. A comparison of methods for adaptive treatment selection.
Friede T; Stallard N
Biom J; 2008 Oct; 50(5):767-81. PubMed ID: 18932136
[TBL] [Abstract][Full Text] [Related]
20. Comparison of treatment effect from randomised controlled phase II trials and subsequent phase III trials using identical regimens in the same treatment setting.
Liang F; Wu Z; Mo M; Zhou C; Shen J; Wang Z; Zheng Y
Eur J Cancer; 2019 Nov; 121():19-28. PubMed ID: 31526874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
